Latest stories on QNRX
Quoin Pharmaceuticals registers to sell 9.37M ADRs for holders
The Fly28 · bearishgeneral
Quoin Pharmaceuticals Ltd. (QNRX) files 8-K
SEC 8-K50 · neutralgeneral
CORRECTION -- Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome
GlobeNewswire67 · bullishproduct/pr
Quoin Pharmaceuticals granted Rare Pediatric Disease Designation for QRX003
The Fly63 · neutralproduct/pr
Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome
GlobeNewswire63 · neutralproduct/pr
Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome
Business Insider63 · neutralproduct/pr
Quoin Reports Positive Interim QRX003 Netherton Data
TipRanks67 · bullishproduct/pr
Quoin Pharmaceuticals, Ltd. (QNRX) files 8-K
SEC 8-K50 · neutralgeneral
Quoin Pharmaceuticals secures up to $50M financing to fund rare disease pipeline; shares rally
Seeking Alpha24 · bearishgeneral
Quoin Pharmaceuticals announces $50M private placement
The Fly24 · bearishgeneral
Quoin Pharmaceuticals reports ‘positive’ data from Phase 2/3 study of QRX003
The Fly63 · neutralproduct/pr
Quoin Pharmaceuticals Announces Private Placement Financing of Up to $50.0 Million
Business Insider28 · bearishgeneral
Quoin Pharmaceuticals Reports Positive Interim Data from Ongoing Phase 2/3 Study of QRX003 in Netherton Syndrome
StockTitan67 · bullishproduct/pr
Quoin Pharmaceuticals Announces Private Placement Financing of Up to $50.0 Million
StockTitan28 · bearishgeneral
Quoin Pharmaceuticals Announces Private Placement Financing of Up to $50.0 Million
GlobeNewswire28 · bearishgeneral
Quoin Pharmaceuticals, Ltd. (QNRX) files 8-K
SEC 8-K50 · neutralgeneral
Quoin Pharmaceuticals, Ltd. (QNRX) files 8-K
SEC 8-K50 · neutralgeneral
Quoin Pharmaceuticals GAAP EPS of -$1.90 misses by $0.29
Seeking Alpha34 · bearishearnings
Quoin Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2026 Financial Results
GlobeNewswire63 · neutralearnings
Quoin Pharmaceuticals to Announce Corporate Update and Second Quarter 2026 Financial Results on Friday, August 14, 2026
Business Insider50 · neutralgeneral
Quoin Pharmaceuticals Receives FDA IND Clearance to Initiate Phase 2 Study of QRX003 in Peeling Skin Syndrome | QNRX Stock News
StockTitan67 · bullishproduct/pr
Quoin Advances QYLEKI Toward First Netherton Therapy
TipRanks59 · neutralproduct/pr